Review





Similar Products

95
Miltenyi Biotec anti cd11c
Anti Cd11c, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd11c/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd11c - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec cd11c antibody, anti-mouse, reafinity
Cd11c Antibody, Anti Mouse, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd11c antibody, anti-mouse, reafinity/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd11c antibody, anti-mouse, reafinity - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec d apc cd11c
(A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and <t>CD11c.</t> Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
D Apc Cd11c, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d apc cd11c/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
d apc cd11c - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

97
Miltenyi Biotec cd11c viobright b515
(A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and <t>CD11c.</t> Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
Cd11c Viobright B515, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd11c viobright b515/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
cd11c viobright b515 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

94
Miltenyi Biotec reafinitytm
(A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and <t>CD11c.</t> Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reafinitytm/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
reafinitytm - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

95
Miltenyi Biotec human anti mouse cd11c igg antibody
(A) Microscopic images from immature BM-DCs isolated from a CB57Bl/6 mouse (left panel), iniDCs after 7 days stimulation with Dex/Dox (middle panel), and de-iniDCs after 3 days of deinduction (right panel). Upon deinduction, de-iniDCs display an adherent phenotype as well as typical dendritic extensions indicated by arrows. During their immortal period, iniDCs lose typical dendritic morphology, become round-shaped, and pass over in suspension. (10 x magnification, bar = 50 µm) (B) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained with fluorochrome-conjugated antibodies against specific dendritic surface markers <t>CD11c,</t> MHC II, CD40, and CD86 and analyzed by flow cytometry. Dead cells were removed by PO-PRO TM -1 Iodide staining. Experiments were performed 3 times independently. Given is the result of one representative experiment. (C) Displayed are the geometric means (MFI) of the cell surface markers, with the background signal subtracted. dark grey = BM-DCs, white = iniDCs, light grey = de-iniDCs, (n = 6), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***).
Human Anti Mouse Cd11c Igg Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human anti mouse cd11c igg antibody/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
human anti mouse cd11c igg antibody - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd11c apc vio 770
(A) Microscopic images from immature BM-DCs isolated from a CB57Bl/6 mouse (left panel), iniDCs after 7 days stimulation with Dex/Dox (middle panel), and de-iniDCs after 3 days of deinduction (right panel). Upon deinduction, de-iniDCs display an adherent phenotype as well as typical dendritic extensions indicated by arrows. During their immortal period, iniDCs lose typical dendritic morphology, become round-shaped, and pass over in suspension. (10 x magnification, bar = 50 µm) (B) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained with fluorochrome-conjugated antibodies against specific dendritic surface markers <t>CD11c,</t> MHC II, CD40, and CD86 and analyzed by flow cytometry. Dead cells were removed by PO-PRO TM -1 Iodide staining. Experiments were performed 3 times independently. Given is the result of one representative experiment. (C) Displayed are the geometric means (MFI) of the cell surface markers, with the background signal subtracted. dark grey = BM-DCs, white = iniDCs, light grey = de-iniDCs, (n = 6), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***).
Anti Cd11c Apc Vio 770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd11c apc vio 770/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd11c apc vio 770 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


(A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).

Journal: Bio-protocol

Article Title: Nuclei Isolation Methods on Frozen Clotted Blood Samples

doi: 10.21769/BioProtoc.5573

Figure Lengend Snippet: (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).

Article Snippet: Flow cytometry antibodies (only applicable if flow sorting) a. FITC CD3 antibody (Miltenyi Biotec, catalog number: 130-113-700) b. PE CD19 antibody (Miltenyi Biotec, catalog number: 130-114-172) c. VioBlue CD11B (Miltenyi Biotec, catalog number: 130-110-616) d. APC CD11C (Miltenyi Biotec, catalog number: 130-114-110) e. Other antibodies (optional): Add other suitable antibodies to tailor the cell population of interest 3.

Techniques: Isolation, Staining, Marker

(A) Microscopic images from immature BM-DCs isolated from a CB57Bl/6 mouse (left panel), iniDCs after 7 days stimulation with Dex/Dox (middle panel), and de-iniDCs after 3 days of deinduction (right panel). Upon deinduction, de-iniDCs display an adherent phenotype as well as typical dendritic extensions indicated by arrows. During their immortal period, iniDCs lose typical dendritic morphology, become round-shaped, and pass over in suspension. (10 x magnification, bar = 50 µm) (B) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained with fluorochrome-conjugated antibodies against specific dendritic surface markers CD11c, MHC II, CD40, and CD86 and analyzed by flow cytometry. Dead cells were removed by PO-PRO TM -1 Iodide staining. Experiments were performed 3 times independently. Given is the result of one representative experiment. (C) Displayed are the geometric means (MFI) of the cell surface markers, with the background signal subtracted. dark grey = BM-DCs, white = iniDCs, light grey = de-iniDCs, (n = 6), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***).

Journal: PLOS One

Article Title: Inducible immortalized Dendritic Cells enable antigen-specific antibody production in a murine in vitro Immunization model

doi: 10.1371/journal.pone.0339883

Figure Lengend Snippet: (A) Microscopic images from immature BM-DCs isolated from a CB57Bl/6 mouse (left panel), iniDCs after 7 days stimulation with Dex/Dox (middle panel), and de-iniDCs after 3 days of deinduction (right panel). Upon deinduction, de-iniDCs display an adherent phenotype as well as typical dendritic extensions indicated by arrows. During their immortal period, iniDCs lose typical dendritic morphology, become round-shaped, and pass over in suspension. (10 x magnification, bar = 50 µm) (B) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained with fluorochrome-conjugated antibodies against specific dendritic surface markers CD11c, MHC II, CD40, and CD86 and analyzed by flow cytometry. Dead cells were removed by PO-PRO TM -1 Iodide staining. Experiments were performed 3 times independently. Given is the result of one representative experiment. (C) Displayed are the geometric means (MFI) of the cell surface markers, with the background signal subtracted. dark grey = BM-DCs, white = iniDCs, light grey = de-iniDCs, (n = 6), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***).

Article Snippet: Before analysis, iniDCs and de-iniDCs were additionally stained with PE-conjugated recombinant human-anti-mouse-CD11c-IgG antibody (Miltenyi Biotec, Bergisch Gladbach, Germany, Ref.: 130-110-701, Lot: 5190521242) and 1 μg/ml PO-PRO TM -1 Iodide (Thermo Fisher, Massachusetts, USA) as described above.

Techniques: Isolation, Suspension, Staining, Flow Cytometry, Two Tailed Test

(A) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained for CD11c and PO-PRO-1 Iodide to define the amount of living CD11c + cells by flow cytometry. After 9 days only 67% (±3.1%) of BM-DCs were alive, 7 days after Dex/Dox stimulation iniDCs displayed 83% (± 2.5%) living cells, and upon deinduction of 3 days vitality decreased to 70% (± 3.8%) of de-iniDCs, n = 3 (B) Vitality of iniDCs was stable for 42 days. After 21 days, 88% (± 2.5%, n = 3) and after 42 days, 87% of the CD11c + cells were alive. (C) For proliferation analysis best results were achieved by staining 35 x 10 5 iniDCs with 10 µM CFSE in PBS only. CD11c + cells were analyzed at day 1 (black) and 11 (green) using the BD FACSDAria III TM as well as an unstained control (grey). (D) de-iniDCs were stained with CFSE and measured at day 0, 1, 2, 3 and 4 as well as an unstained control.

Journal: PLOS One

Article Title: Inducible immortalized Dendritic Cells enable antigen-specific antibody production in a murine in vitro Immunization model

doi: 10.1371/journal.pone.0339883

Figure Lengend Snippet: (A) Respectively, 5 x 10 5 BM-DCs, iniDCs, and de-iniDCs were stained for CD11c and PO-PRO-1 Iodide to define the amount of living CD11c + cells by flow cytometry. After 9 days only 67% (±3.1%) of BM-DCs were alive, 7 days after Dex/Dox stimulation iniDCs displayed 83% (± 2.5%) living cells, and upon deinduction of 3 days vitality decreased to 70% (± 3.8%) of de-iniDCs, n = 3 (B) Vitality of iniDCs was stable for 42 days. After 21 days, 88% (± 2.5%, n = 3) and after 42 days, 87% of the CD11c + cells were alive. (C) For proliferation analysis best results were achieved by staining 35 x 10 5 iniDCs with 10 µM CFSE in PBS only. CD11c + cells were analyzed at day 1 (black) and 11 (green) using the BD FACSDAria III TM as well as an unstained control (grey). (D) de-iniDCs were stained with CFSE and measured at day 0, 1, 2, 3 and 4 as well as an unstained control.

Article Snippet: Before analysis, iniDCs and de-iniDCs were additionally stained with PE-conjugated recombinant human-anti-mouse-CD11c-IgG antibody (Miltenyi Biotec, Bergisch Gladbach, Germany, Ref.: 130-110-701, Lot: 5190521242) and 1 μg/ml PO-PRO TM -1 Iodide (Thermo Fisher, Massachusetts, USA) as described above.

Techniques: Staining, Flow Cytometry, Control

(A) 5 x 10 5 de-iniDCs were stimulated with or without 2 µg/ml DQ-Ova for 60 min at 37°C and measured by fluorescence microscopy using the BZ-800 Biozero (10 x magnification, bar = 50 µm), (B) 1 x 10 5 C57Bl/6 BM-DCs and de-iniDCs were challenged with 1 µg/ml DQ-Ova for 60 min at 37°C (black) and analyzed by flow cytometry using the Attune ® Acoustic Focusing Cytometer. Controls are depicted in grey. Given is the result of one representative experiment out of three. (C) After maturation of the de-iniDCs with VP1, respectively 5 x 10 5 cells were stained with fluorochrome-labeled antibodies against maturation markers CD11c, MHC II, CD40, or CD86. To exclude dead cells 1 µg/ml PO-PRO-1 TM Iodide was added before analysis using the Attune® Acoustic Focusing Cytometer. Unstained control is in light grey, immature DCs in dark grey, and mature DCs are in black. Given is one representative result out of three. (D) Displayed are the geometric means (MFI) of the different surface receptors before and after maturation with VP1. The background signal was subtracted. (n = 8), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***) (E) 1x10 6 de-iniDCs were matured with 15 µg/ml VP1 for 24 h, and supernatant was analyzed for IL-10 and IL-12p70 by ELISA. (n = 3).

Journal: PLOS One

Article Title: Inducible immortalized Dendritic Cells enable antigen-specific antibody production in a murine in vitro Immunization model

doi: 10.1371/journal.pone.0339883

Figure Lengend Snippet: (A) 5 x 10 5 de-iniDCs were stimulated with or without 2 µg/ml DQ-Ova for 60 min at 37°C and measured by fluorescence microscopy using the BZ-800 Biozero (10 x magnification, bar = 50 µm), (B) 1 x 10 5 C57Bl/6 BM-DCs and de-iniDCs were challenged with 1 µg/ml DQ-Ova for 60 min at 37°C (black) and analyzed by flow cytometry using the Attune ® Acoustic Focusing Cytometer. Controls are depicted in grey. Given is the result of one representative experiment out of three. (C) After maturation of the de-iniDCs with VP1, respectively 5 x 10 5 cells were stained with fluorochrome-labeled antibodies against maturation markers CD11c, MHC II, CD40, or CD86. To exclude dead cells 1 µg/ml PO-PRO-1 TM Iodide was added before analysis using the Attune® Acoustic Focusing Cytometer. Unstained control is in light grey, immature DCs in dark grey, and mature DCs are in black. Given is one representative result out of three. (D) Displayed are the geometric means (MFI) of the different surface receptors before and after maturation with VP1. The background signal was subtracted. (n = 8), two-tailed t-test (p < 0,05 = *; p < 0,01 = **; p < 0,001 = ***) (E) 1x10 6 de-iniDCs were matured with 15 µg/ml VP1 for 24 h, and supernatant was analyzed for IL-10 and IL-12p70 by ELISA. (n = 3).

Article Snippet: Before analysis, iniDCs and de-iniDCs were additionally stained with PE-conjugated recombinant human-anti-mouse-CD11c-IgG antibody (Miltenyi Biotec, Bergisch Gladbach, Germany, Ref.: 130-110-701, Lot: 5190521242) and 1 μg/ml PO-PRO TM -1 Iodide (Thermo Fisher, Massachusetts, USA) as described above.

Techniques: Fluorescence, Microscopy, Flow Cytometry, Cytometry, Staining, Labeling, Control, Two Tailed Test, Enzyme-linked Immunosorbent Assay